Precision Quantomics

As we celebrate this season of gratitude, the team at Precision Quantomics extends our heartfelt thanks to our clients, partners, and supporters. Your collaboration and trust empower us to advance science and innovation in ways that truly make a difference. This Thanksgiving, we reflect on the achievements we’ve shared and the exciting journey ahead. Thank you for being part of our story. From all of us at Precision Quantomics, Happy Thanksgiving to you and your loved ones! #HappyThanksgiving #Gratitude #Teamwork #PrecisionQuantomics

The Challenge of Drug Development: Are You Missing Critical Insights? Drug discovery and development are fraught with challenges—one of the most significant being the inability to fully understand how potential therapies interact with complex biological systems. Traditional approaches often fall short in providing the depth of insight needed to optimize candidate selection and predict clinical outcomes. This is where proteomics changes the game. By enabling the detailed study of protein dynamics, interactions, and functions, proteomics empowers researchers to uncover hidden mechanisms, identify novel biomarkers, and accelerate drug development timelines. Join Dr. Faizan Zubair?for an exclusive webinar on how advanced proteomics technologies are transforming drug discovery and development. With years of expertise and cutting-edge insights, Dr. Zubair will share practical strategies and success stories that showcase the power of proteomics in tackling drug development challenges.

Learn how proteomics can accelerate drug discovery with Dr. Faizan Zubair, an industry expert who will explore cutting-edge technologies shaping the future of medicine. Wed, Dec 4, 2024 10:30 AM - 11:30 AM PST hosted by Precision Quantomics. Register here: https://lnkd.in/gdYePrXg With 8 years in the pharmaceutical industry, Faizan specializes in proteomics, bioanalysis, and DMPK. At Takeda, he led the translational biomarker core, collaborating across toxicology and clinical biomarker teams. His expertise spans mass spectrometry platforms, including triple quadrupoles and orbitraps, and techniques like immunoprecipitation and chemical enrichment. Faizan applies proteomics for target ID, biomarker discovery, and plasma protein stability in drug development.

Is it time to rethink animal models in research? Each year, 192 million lab mice are used globally. While they’ve been essential to past breakthroughs, emerging technologies like proteomics and advanced modeling offer faster, more translatable, and ethical alternatives. How can we innovate to reduce reliance on animal models while maintaining scientific rigor? What do you think the future holds for research? https://lnkd.in/g3Q7j4zt

Unlock the power of proteomics to accelerate drug discovery with Dr. Faizan Zubair, an industry expert who will explore cutting-edge technologies shaping the future of medicine. In this exclusive webinar, gain practical insights into overcoming key challenges in drug development and discover how proteomics can streamline your path from research to impactful results. About the Webinar Host: Dr. Zubair earned his PhD in Chemical and Biomolecular Engineering from Vanderbilt University, where he trained in Dr. Richard Caprioli's Mass Spectrometry Research Center. With 8 years in the pharmaceutical industry, Faizan specializes in proteomics, bioanalysis, and DMPK. At Takeda, he led the translational biomarker core, collaborating across toxicology and clinical biomarker teams. His expertise spans mass spectrometry platforms, including triple quadrupoles and orbitraps, and techniques like immunoprecipitation and chemical enrichment. Faizan applies proteomics for target ID, biomarker discovery, and plasma protein stability in drug development.

Glad to join and reconnect with so many familiar trailblazers from the region at the Founders, Funders, and Friends event! It’s always inspiring to be surrounded by those driving innovation and supporting the entrepreneurial journey in our community. A big thank you to the organizers— Greater Spokane Incorporated Health Sciences & Services Authority (HSSA), LaunchPad INW, and NextLevelVenture —as well as the sponsors, Bouten Construction Company and, My Green Lab for making this event possible! Grateful for the chance to share Precision Quantomics’ vision and connect with such a dynamic group. Michaele Armstrong, PhD, MBA Thank you for your leadership in organizing this fabulous event! #Entrepreneurship #Innovation #Networking #Bioscience #Bullpen #LifeScienceWashington #FoundersFundersFriends #Trailblazers #PrecisionQuantomics #Community #StartupLife"

We’re thrilled to announce that Dr. Faizan Zubair, a leader in proteomics and drug discovery, will be joining Precision Quantomics for an upcoming webinar! Join us as Dr. Zubair delves into “Proteomics Technology and Its Applications in Drug Discovery”, exploring the groundbreaking technologies shaping the future of medicine. ?? Whether you’re in pharma, biotech, or academia, this session offers insights to transform your approach to drug development, reduce R&D timelines, and improve outcomes. ?? Date: Wednesday December 4 ?? Time: 10:30am ?? https://lnkd.in/gnFsCv2H Don’t miss out on the chance to hear directly from an expert in the field! Register now to secure your spot and take part in this valuable discussion. #Webinar #Proteomics #DrugDiscovery #PrecisionQuantomics #Pharma #Biotech

?? Excited to share that Precision Quantomics will be pitching at this year’s Founders, Funders & Friends Event on November 12! Join us to hear from groundbreaking entrepreneurs advancing bioscience, and be sure to cast your vote for your favorite pitch. Register here to be part of the event: https://bit.ly/40sMHht Precision Quantomics is pioneering drug development tools in quantitative proteomics, offering researchers new levels of insight into drug interactions and safety, especially for underrepresented populations. Thanks to recent funding from National Institute on Minority Health and Health Disparities (NIMHD), Health Sciences & Services Authority (HSSA), and Life Science Washington, we are expanding our impact in bioscience. A big thank you to sponsors, Bouten Construction Company and My Green Lab My Green Lab, for making this event possible. Let’s support innovation in drug development—don’t forget to vote at the event! ???? #FoundersFundersFriends #bioscience #drugdevelopment #pitchday #PrecisionQuantomics #SpokaneStartup

New research highlights how proteomics and mass spectrometry are uncovering biomarkers critical to disease progression and therapeutic outcomes, emphasizing their role in advancing personalized medicine. Read full study for detailed insights! https://lnkd.in/gNgtX6ZS #Proteomics #MassSpectrometry #PersonalizedMedicine #Biomarkers #CYP450

A recent study explores how mass spectrometry-based proteomics can improve therapeutic monitoring by providing detailed protein profiles that reflect disease progression and treatment response. This research highlights proteomics’ potential to enhance personalized medicine, helping to tailor therapies based on individual biological markers. For those interested in precision medicine advancements, read more in the full study on PubMed: Link to study #Proteomics #PrecisionMedicine #MassSpectrometry #LifeSciences